Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71.
This unique rating tracks technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research reveals that the market's biggest winners typically have an RS Rating north of 80 in the early stages of their moves. See if Stryker stock can continue to show renewed price strength and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Is Stryker Stock A Buy?
Stryker is working on a flat base with a 361.41 buy point. See if the medical device maker stock can break out in volume at least 40% higher than normal.
Earnings growth increased last quarter from 15% to 17%. But sales fell from 12% to 10%.
Stryker stock holds the No. 13 rank among its peers in the Medical-Products industry group. LeMaitre Vascular, Globus Medical and ResMed are among the top 5 highly rated stocks within the group.
